High-level primary CD8+ T-cell response to human immunodeficiency virus type 1 Gag and Env generated by vaccination with recombinant vesicular stomatitis viruses

Journal of Virology

Volumn 76, Issue 6, 2002, Pages 2730-2738

  Haglund, Karl ^a   Leiner, Ingrid ^a   Kerksiek, Kristen ^a   Buonocore, Linda ^a   Pamer, Eric ^a   Rose, John K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAG PROTEIN; GAMMA INTERFERON; PADGEM PROTEIN; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; VACCINATION; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS RECOMBINANT;

AIDS VACCINES; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENETIC VECTORS; HIV-1; HUMANS; MICE; MICE, INBRED BALB C; RECOMBINATION, GENETIC; VACCINATION; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 0036184412     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.6.2730-2738.2002     Document Type: Article

References (51)

1. Phenotypic analysis of antigen-specific T lymphocytes
2. Changes in cell adhesion molecule expression on T cells associated with systemic virus infection
3. Lymphocytic choriomeningitis virus infection is associated with long-standing perturbation of LFA-1 expression on CD8+ T cells
4. + T cells
5. Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immuno-deficiency virus epitopes by DNA vaccination of rhesus monkeys
6. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
7. Coordinate regulation of complex T cell populations responding to bacterial infection
8. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo
9. Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody
10. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: Analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses
11. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes
12. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: High-level production of virus-like particles containing HIV envelope
13. CD8+ T cell effector mechanisms in resistance to infection
14. Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis
15. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions
16. + cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins
17. Down-regulation of homing receptors after T cell activation
18. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses
19. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses
20. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector
21. Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals
22. Induction and visualization of mucosal memory CD8 T cells following systemic virus infection
23. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
24. Recombinant vesicular stomatitis viruses from DNA
25. The role of beta7 integrins in CD8 T cell trafficking during an antiviral immune response
26. Direct analysis of the dynamics of the intestinal mucosa CD8 T cell response to systemic virus infection
27. Preferential localization of effector memory cells in nonlymphoid tissue
28. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D
29. Analysis of HIV particle formation using transient expression of subviral constucts in mammalian cells
30. A high proportion of T lymphocytes that infiltrate H-2-incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific scrine proteases, but do not express the MEL-14-defined lymph node homing receptor
31. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
32. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
33. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study
34. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
35. N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells
36. Attenuated vesicular stomatitis viruses as vaccine vectors
37. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge
38. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
39. The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma
40. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies
41. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles
42. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus
43. Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer
44. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge
45. Degenerate MHC restriction reveals the contribution of class I MHC molecules in determining the fine specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160 V3 loop
46. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules
47. Vaccinia virus immune evasion
48. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule
49. Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction
50. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes
51. Cell-mediated immunity to vesicular stomatitis virus infections in mice